In this study, we investigated the efficacy of targeted systemic delivery of TNFα for the treatment of medulloblastoma by using a tumor‐selective RGD4C.TPA‐mediated TNFα gene delivery platform. The gene discussed is TNF; the disease is medulloblastoma.